Effects of Step Training in Older Adults with Mild Dementia
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Dec 15, 2022
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special step training program can help older adults with mild dementia improve their walking and reduce their risk of falling. The program combines stepping exercises with tasks that require attention and focus, which are important for safe movement. Researchers want to learn how this training affects not just walking ability, but also how the brain functions when making stepping decisions. This could help develop better ways to keep older adults with dementia safe and independent.
To participate, you need to be at least 65 years old and have a diagnosis of mild dementia. You should also be able to walk 10 meters on your own without needing a walking aid and have a caregiver who can help you. If you join the trial, you can expect to take part in the step training program and be assessed on your walking skills and balance. This study is currently recruiting participants, so it’s a great opportunity to contribute to important research that could benefit many older adults with dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 65 years old;
- • have a physician's diagnosis of dementia according to the Diagnostic and Statistical Manual of Mental Disorders 5th edition;
- • have mild dementia, indicated by a score of 10 or higher on the Montreal Cognitive Assessment Hong Kong version (HK-MoCA);
- • able to walk 10 meters independently without a walking aid;
- • receiving care by an unpaid "main caregiver" with at least 3.5 hours of face-to-face contact per week.
- Exclusion Criteria:
- • unable to perform step training due to unstable or severe musculoskeletal, cardiorespiratory, or neurological conditions;
- • have severe hearing and/or visual impairments that limit their ability to communicate;
- • have been hospitalized within the past 30 days.
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, Hong Kong
Patients applied
Trial Officials
Wayne LS Chan, PhD
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials